Shield Therapeutics to Present at BIO-Europe Spring 2011

9 Mar 2011

Shield Holdings AG (Shield), the independent specialty pharmaceutical company focused on the development and commercialisation of late-stage hospital pharmaceuticals, today announces that Carl Sterritt, Chief Executive Officer, and Dr Christian Schweiger, Chief Medical Officer, will attend BIO-Europe Spring Conference at the Milano Convention Centre in Milan, Italy. Dr Schweiger will present an update on Shield at the conference on Tuesday 15 March, 2011 at 10:15 CET.

Back to news